Back to search

University of Ioannina

Καρδιομεταβολικοί παράγοντες κινδύνου και φαρμακευτική αγωγή ομάδων ασθενών υψηλού , μεσαίου και χαμηλού καρδιαγγειακού κινδύνου

Abstract

dc:description

Introduction: Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, imposing a substantial burden on healthcare systems and public health. Their effective prevention and management require the timely identification and adequate control of cardiometabolic risk factors, including dyslipidemia, arterial hypertension, and diabetes mellitus. However, the clinical effectiveness of available therapeutic interventions depends not only on appropriate prescribing and timely treatment initiation, but also on consistent medication use and long-term treatment persistence. Aim and Methodology: The aim of the present doctoral dissertation was to investigate the relationships among cardiometabolic risk factors, overall cardiovascular risk, and medication-taking behavior in individuals receiving lipid-lowering, antihypertensive, or antidiabetic therapy. The dissertation comprised two systematic reviews and meta-analyses examining medication adherence to statin therapy, as well as a primary epidemiological study involving 1,019 adult participants in Greece. Medication adherence was quantified using the Proportion of Days Covered (PDC), with a threshold of 80% defining adequate adherence, while treatment persistence and time to first discontinuation were evaluated using Kaplan–Meier curves and Cox proportional hazards models. Results: Substantial differences in medication adherence were observed across therapeutic categories, with antihypertensive therapy demonstrating the lowest rate of adequate adherence and the highest frequency of treatment discontinuation. Secondary prevention and higher cardiovascular risk categories were associated with more favorable medication-taking behavior. Furthermore, multimorbidity and polypharmacy were associated, within specific therapeutic cohorts, with an increased likelihood of adequate medication adherence. Conversely, specific sociodemographic and clinical characteristics were associated with lower adherence or an increased risk of early treatment discontinuation. Conclusions: Medication adherence and treatment persistence are fundamental determinants of the effectiveness of cardiovascular prevention interventions. The systematic identification of patients at increased risk of inadequate adherence or premature discontinuation may support the development of individualized monitoring, educational, and patient-empowerment interventions. The implementation of such strategies by multidisciplinary healthcare teams may facilitate the achievement of therapeutic targets, improve clinical outcomes, and reduce the healthcare and socioeconomic burden of cardiovascular disease. Keywords: cardiometabolic risk factors, medication adherence, treatment persistence, treatment discontinuation, atherosclerotic cardiovascular disease, epidemiology, public health.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Basios, Athanasios
  • Μπάσιος, Αθανάσιος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62269

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Basios, Athanasios; Μπάσιος, Αθανάσιος. Καρδιομεταβολικοί παράγοντες κινδύνου και φαρμακευτική αγωγή ομάδων ασθενών υψηλού , μεσαίου και χαμηλού καρδιαγγειακού κινδύνου. University of Ioannina, 2026. http://hdl.handle.net/10442/hedi/62269